<DOC>
	<DOCNO>NCT01693692</DOCNO>
	<brief_summary>The purpose study study determine whether TD-9855 effective treating patient fibromyalgia .</brief_summary>
	<brief_title>Phase 2 Study TD-9855 Treat Fibromyalgia</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<criteria>• American College Rheumatology ( ACR ) Diagnostic Criteria Fibromyalgia ( FM ) Informed consent 18 65 year age Discontinue therapy adrenergicacting drug , certain medication Only acetaminophen NSAID rescue pain medication No narcotic pain med benzodiazepines Only nonbenzodiazepines rescue hypnotic Any current psychiatric disorder , lifetime bipolar disorder , severe comorbid Axis II disorder , mental retardation , etc , assess Mini International Neuropsychiatric Interview ( MINI ) Major depression screen MINI unable wash MDD med ( investigator provider 's judgment ) Risk suicide ( investigator opinion and/or CSSRS ) Recent history substance alcohol abuse BMI &lt; 18 ≥45 Concurrent disease ; pain diagnose illness FM ; noncompliance ; history seizure ; pheochromocytoma ; glaucoma ; CV disease ; orthostatic hypotension orthostatic tachycardia ; untreated sleep apnea Abnormal lab value ( liver , kidney , thyroid , others )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Fibromyalgia</keyword>
</DOC>